TY - JOUR
T1 - Evaluation of humoral immune status in porcine epidemic diarrhea virus (PEDV) infected sows under field conditions
AU - Ouyang, Kang
AU - Shyu, Duan Liang
AU - Dhakal, Santosh
AU - Hiremath, Jagadish
AU - Binjawadagi, Basavaraj
AU - Lakshmanappa, Yashavanth S.
AU - Guo, Rui
AU - Ransburgh, Russell
AU - Bondra, Kathryn M.
AU - Gauger, Phillip
AU - Zhang, Jianqiang
AU - Specht, Terry
AU - Gilbertie, Aaron
AU - Minton, William
AU - Fang, Ying
AU - Renukaradhya, Gourapura J.
N1 - Publisher Copyright:
© 2015 Ouyang et al.
PY - 2015/12/14
Y1 - 2015/12/14
N2 - Porcine epidemic diarrhea virus (PEDV) is an economically devastating enteric disease in the swine industry. The virus infects pigs of all ages, but it cause severe clinical disease in neonatal suckling pigs with up to 100% mortality. Currently, available vaccines are not completely effective and feedback methods utilizing PEDV infected material has variable success in preventing reinfection. Comprehensive information on the levels and duration of effector/memory IgA and IgG antibody secreting B cell response in the intestines and lymphoid organs of PEDV-infected sows, and their association with specific antibody levels in clinical samples such as plasma, oral fluid, and feces is important. Therefore, our goal in this study was to quantify PEDV specific IgA and IgG B cell responses in sows at approximately 1 and 6 months post-infection in commercial swine herds, including parity one and higher sows. Our data indicated that evaluation of both PEDV specific IgA and IgG antibody levels in the plasma and oral fluid (but not feces) samples is beneficial in disease diagnosis. PEDV specific B cell response in the intestine and spleen of infected sows decline by 6 months, and this associates with specific antibody levels in the plasma and oral fluid samples; but the virus neutralization titers in plasma remains high beyond 6 months post-infection. In conclusion, in sows infected with PEDV the presence of effector/memory B cell response and strong virus neutralization titers in plasma up to 6 months post-infection, suggests their potential to protect sows from reinfection and provide maternal immunity to neonates, but challenge studies are required to confirm such responses.
AB - Porcine epidemic diarrhea virus (PEDV) is an economically devastating enteric disease in the swine industry. The virus infects pigs of all ages, but it cause severe clinical disease in neonatal suckling pigs with up to 100% mortality. Currently, available vaccines are not completely effective and feedback methods utilizing PEDV infected material has variable success in preventing reinfection. Comprehensive information on the levels and duration of effector/memory IgA and IgG antibody secreting B cell response in the intestines and lymphoid organs of PEDV-infected sows, and their association with specific antibody levels in clinical samples such as plasma, oral fluid, and feces is important. Therefore, our goal in this study was to quantify PEDV specific IgA and IgG B cell responses in sows at approximately 1 and 6 months post-infection in commercial swine herds, including parity one and higher sows. Our data indicated that evaluation of both PEDV specific IgA and IgG antibody levels in the plasma and oral fluid (but not feces) samples is beneficial in disease diagnosis. PEDV specific B cell response in the intestine and spleen of infected sows decline by 6 months, and this associates with specific antibody levels in the plasma and oral fluid samples; but the virus neutralization titers in plasma remains high beyond 6 months post-infection. In conclusion, in sows infected with PEDV the presence of effector/memory B cell response and strong virus neutralization titers in plasma up to 6 months post-infection, suggests their potential to protect sows from reinfection and provide maternal immunity to neonates, but challenge studies are required to confirm such responses.
UR - http://www.scopus.com/inward/record.url?scp=84951064820&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84951064820&partnerID=8YFLogxK
U2 - 10.1186/s13567-015-0285-x
DO - 10.1186/s13567-015-0285-x
M3 - Article
C2 - 26667229
AN - SCOPUS:84951064820
SN - 0928-4249
VL - 46
JO - Veterinary research
JF - Veterinary research
IS - 1
M1 - 285
ER -